Related Experiment Videos
Updating meta-analytic research findings: Bayesian approaches versus the medical model
Frank L Schmidt1, Nambury S Raju
1Department of Management and Organizations, Henry B. Tippie College of Business, University of Iowa, Iowa City, IA 52242, USA. frank-schmidt@uiowa.edu
Abstract:
The authors examine 3 methods of combining new studies into existing meta-analyses: (a) adding the new study or studies to the database and recalculating the meta-analysis (the medical model); (b) using the Bayesian procedure advocated by F. L. Schmidt and J. E. Hunter (1977) and F. L. Schmidt, J. E. Hunter, K. Pearlman, and G. S. Shane (1979) to update the meta-analysis; and (c) using the Bayesian methods advocated by these authors and M. T. Brannick (2001) and M. T. Brannick, S. M. Hall, and Y. Liu (2002) to estimate study-specific parameters. Method b was found to severely overweight new studies relative to the previous studies contained in the meta-analysis, and Method c was found to do the same while also requiring an assumption with a low prior probability of being correct, causing the method to violate Bayesian principles. The authors present an alternative Bayesian procedure that does not suffer from these drawbacks and yields meta-analytic results very similar to those obtained with the medical model. They recommend use of the medical model or this alternative Bayesian procedure.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Kaplan-Meier Approach
Comparing the Survival Analysis of Two or More Groups
Regression Toward the Mean
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...